← Back to Bills
HR 9627118th CongressFailed / ExpiredHouse

Biotech Futures Act

Policy Area: Armed Forces and National Security
View on Congress.gov
Origin Chamber
House
Last Updated
Sep 9, 2025
Latest Action Date
Sep 17, 2024

Latest Action

Referred to the House Committee on Armed Services.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Biotech Futures Act (H.R. 9627) was a bill introduced in the 118th Congress aimed at addressing issues related to biotechnology within the context of armed forces and national security. The bill was referred to the House Committee on Armed Services but ultimately failed or expired without further legislative action. Specific details about the bill's provisions, objectives, or funding mechanisms are not available in the provided data.

Bottom Line

H.R. 9627, the Biotech Futures Act, intended to impact biotechnology in national security but did not advance beyond committee referral and expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill was introduced in the House during the 118th Congress and referred to the House Committee on Armed Services.
  • It is categorized under the policy area of Armed Forces and National Security.
  • No official summary or full text is available, limiting detailed analysis of its content or provisions.
Who Benefits?

['Potential beneficiaries could include the Department of Defense, biotechnology industries involved in national security applications, and related research organizations, though specifics are not provided.']

Potential Concerns

['Lack of available text and summary limits understanding of implementation requirements, funding sources, and oversight mechanisms.', "The bill's failure to progress suggests possible challenges in legislative support or alignment with existing policy priorities."]

Political Context

The bill was introduced in the 118th Congress and referred to the House Committee on Armed Services. It falls within the broader legislative efforts to integrate biotechnology advancements into national security frameworks. However, it did not advance beyond committee referral and expired, indicating it did not receive sufficient legislative momentum during the session.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['If enacted, the bill could have influenced the integration of biotechnology innovations into defense strategies and national security operations.', 'The failure of the bill to advance may delay or limit legislative support for biotechnology initiatives within the armed forces sector.']

GovScope Watchdog Notes

The absence of an official summary and full bill text restricts comprehensive analysis and public transparency. Monitoring similar future bills for detailed disclosures and legislative progress is recommended to ensure informed oversight and stakeholder engagement.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready